Why the study?
It was unknown whether regulator of G-protein signaling-4 modulates cardiac free fatty acid receptor-3 signaling and function.
Population
H9c2 cardiomyocytes and sympathetic-like neurons (differentiated Neuro-2a cells)
Comparison
siRNA-mediated RGS4 depletion and catecholamine pretreatment vs controls
Design
In vitro experimental cell study
Authors
Loading...
RGS4 attenuates FFAR3-driven cardiac inflammation and fibrosis; leaves open its therapeutic targeting in AF.
RGS4 is essential for attenuating propionate/FFAR3 signaling in cardiomyocytes and sympathetic neurons, protecting against inflammation and adverse remodeling.
Carbone et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: